Kornitzer Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,425	Closed	-$541K	–	487
2024 Q2	$541K	Hold	7,425	–	–	0.01%	430
2024 Q1	$440K	Hold	7,425	–	–	0.01%	444
2023 Q4	$544K	Sell	7,425 -2,500	-25%	-$183K	0.01%	429
2023 Q3	$386K	Sell	9,925 -3,000	-23%	-$117K	0.01%	459
2023 Q2	$746K	Hold	12,925	–	–	0.01%	425
2023 Q1	$840K	Hold	12,925	–	–	0.02%	412
2022 Q4	$355K	Hold	12,925	–	–	0.01%	472
2022 Q3	$377K	Hold	12,925	–	–	0.01%	476
2022 Q2	$248K	Sell	12,925 -57,973	-82%	-$1.11M	0.01%	497
2022 Q1	$5.75M	Hold	70,898	–	–	0.09%	252
2021 Q4	$6.49M	Sell	70,898 -1,926	-3%	-$176K	0.1%	253
2021 Q3	$9.1M	Hold	72,824	–	–	0.14%	232
2021 Q2	$8.23M	Buy	72,824 +840	+1%	+$94.9K	0.12%	238
2021 Q1	$10.9M	Buy	71,984 +5,433	+8%	+$823K	0.17%	208
2020 Q4	$7.66M	Sell	66,551 -714	-1%	-$82.2K	0.13%	232
2020 Q3	$5.21M	Buy	67,265 +18,296	+37%	+$1.42M	0.1%	253
2020 Q2	$5.39M	Buy	48,969 +1,942	+4%	+$214K	0.11%	243
2020 Q1	$5.14M	Buy	47,027 +2,574	+6%	+$281K	0.12%	224
2019 Q4	$7.06M	Sell	44,453 -2,703	-6%	-$430K	0.12%	221
2019 Q3	$6.96M	Sell	47,156 -1,134	-2%	-$167K	0.13%	219
2019 Q2	$5.61M	Buy	48,290 +3,556	+8%	+$413K	0.1%	240
2019 Q1	$4.84M	Buy	44,734 +11,992	+37%	+$1.3M	0.09%	253
2018 Q4	$2.67M	Buy	32,742 +11,227	+52%	+$915K	0.05%	279
2018 Q3	$3.5M	Buy	21,515 +6,791	+46%	+$1.1M	0.06%	275
2018 Q2	$2.91M	Buy	+14,724	New	+$2.91M	0.05%	285